Intuitive Surgical (ISRG) experienced a 5.12% plummet during Friday's intraday trading session, underperforming the broader market as the company's slower procedure growth forecast for 2025 weighed on investor sentiment.
The medical technology company reported better-than-expected earnings and revenue for the fourth quarter, driven by strong sales of its da Vinci surgical robots. However, Intuitive Surgical's outlook for 2025 worldwide da Vinci procedure growth of 13% to 16% fell short of the 17% increase witnessed in the previous year, sparking concerns among investors.
Analysts noted that while the guidance was conservative, in line with Intuitive Surgical's typical approach, the slower projected growth rate compared to 2024 contributed to the stock's sell-off. Traders were skeptical about the company's ability to sustain its momentum, given the potential headwinds in certain market segments and the competitive landscape.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。